Will pharma face tougher FDA scrutiny by 2027?
zeitgeist· Science & Health
Will pharma face tougher FDA scrutiny by 2027?
Market overview
Will the FDA increase regulatory scrutiny over pharma and biotech by May 2027? This market tracks potential policy shifts impacting the industry.
Science & Health prediction market
- Implied probability (Yes)
- 51%
- Volume
- $77,000
- Closes
- 2027-05-04
Source: zeitgeist
More Science & Health markets
- Will a major Pharma-Biotech deal be announced by 2026? — 39% Yes
- Will energy topic exceed consensus forecasts by 2027? — 77% Yes
- Will a major nuclear announcement occur before November 2026? — 33% Yes
- Will another major pandemic emerge before May 2027? — 53% Yes
- Will climate change crash markets by Feb 2027? — 22% Yes
- Will climate forecasts exceed by 2027? — 67% Yes
- Will humans land on the Moon before April 2027? — 49% Yes
- Will NASA reveal a major space discovery by Dec 2026? — 40% Yes
No one's made a Conviction call on this yet. Be the first to call it →
Loading…